A team of chemists led by Northwestern University has resolved a structural mystery that lingered for roughly three decades, ...

ACADIA Pharmaceuticals (NASDAQ:ACAD) reported fourth-quarter and full-year 2025 results highlighted by double-digit revenue ...

CollPlant Biotechnologies (Nasdaq: CLGN), a regenerative and aesthetic medicine company developing innovative technologies ...

The MoneyShow Chart of the Day is of the ICE BofA Single-B US High Yield Index Option Adjusted Spread, which shows the extra yield a moderately risky corporate borrower has to offer - above and beyond ...

Bitcoin continues to dip after breaking its 50-week EMA as we predicted in December last year. Weekly RSI hit its lowest level since 2022 and could be nearing a cycle bottom. Long-term holders have ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Florida State football has added 23 transfers and 27 early enrollees to rebuild its roster after a 5-7 season. Key position battles are expected at quarterback, with transfer Ashton Daniels competing ...

Many key items have seen prices rise, not fall, under Trump The price of electricity has risen significantly — almost 7% higher than a year ago. Housing, medical care, and tuition and child care are ...

We’ll soon see if Mizzou’s offseason emphasis on improving the passing game will pay off. Missouri football's wide receiver room is going to look almost entirely different in 2026. Kevin Coleman Jr.

What if there were a way to customize your keyboard that surpasses even the most popular options available today? Below, Better Stack takes you through how Kanata, an open source software, reshapes ...

About BIO-key International Inc. BIO-key International, Inc. engages in the provision of an identity and access management platform. The firm's products include PortalGuard, Admin Panel, Hardware, ...

Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel immuno-oncology ...